Request Demo
Recent blog posts
Latest Hotspot
8 min read
Juvenile dermatomyositis Indication Strategy Report 2026: IFNAR1, Trials and Deals
24 July 2026
2026 Juvenile dermatomyositis strategy: epidemiology, IFNAR1 biology, clinical competition, recent deals, unmet need and market attractiveness.
Latest Hotspot
8 min read
Pemphigus foliaceus Indication Strategy Report 2026: DSG1, Trials and Deals
24 July 2026
2026 Pemphigus foliaceus strategy: epidemiology, DSG1 biology, clinical competition, recent deals, unmet need and market attractiveness. Evidence synthesized…
Latest Hotspot
8 min read
Immune-mediated necrotizing myopathy Indication Strategy Report 2026: FcRn, Trials and Deals
24 July 2026
2026 Immune-mediated necrotizing myopathy strategy: epidemiology, FcRn biology, clinical competition, recent deals, unmet need and market attractiveness.
Latest Hotspot
8 min read
Linear IgA bullous dermatosis Indication Strategy Report 2026: FcRn, Trials and Deals
24 July 2026
2026 Linear IgA bullous dermatosis strategy: epidemiology, FcRn biology, clinical competition, recent deals, unmet need and market attractiveness.
Latest Hotspot
8 min read
Dissecting cellulitis of the scalp Indication Strategy Report 2026: TNF, Trials and Deals
24 July 2026
2026 Dissecting cellulitis of the scalp strategy: epidemiology, TNF biology, clinical competition, recent deals, unmet need and market attractiveness.
Latest Hotspot
8 min read
Epidermolysis bullosa acquisita Indication Strategy Report 2026: COL7A1, Trials and Deals
24 July 2026
2026 Epidermolysis bullosa acquisita strategy: epidemiology, COL7A1 biology, clinical competition, recent deals, unmet need and market attractiveness.
Latest Hotspot
8 min read
Central centrifugal cicatricial alopecia Indication Strategy Report 2026: PPAR-gamma, Trials and Deals
24 July 2026
2026 Central centrifugal cicatricial alopecia strategy: epidemiology, PPAR-gamma biology, clinical competition, recent deals, unmet need and market attractiveness.
Latest Hotspot
8 min read
Frontal fibrosing alopecia Indication Strategy Report 2026: PPAR-gamma, Trials and Deals
24 July 2026
2026 Frontal fibrosing alopecia strategy: epidemiology, PPAR-gamma biology, clinical competition, recent deals, unmet need and market attractiveness.
Latest Hotspot
8 min read
Lichen planopilaris Indication Strategy Report 2026: JAK1, Trials and Deals
24 July 2026
2026 Lichen planopilaris strategy: epidemiology, JAK1 biology, clinical competition, recent deals, unmet need and market attractiveness. Evidence synthesized…
Latest Hotspot
8 min read
Necrobiosis lipoidica Indication Strategy Report 2026: TNF, Trials and Deals
24 July 2026
2026 Necrobiosis lipoidica strategy: epidemiology, TNF biology, clinical competition, recent deals, unmet need and market attractiveness. Evidence synthesized…
Latest Hotspot
8 min read
Granuloma annulare Indication Strategy Report 2026: JAK1, Trials and Deals
24 July 2026
2026 Granuloma annulare strategy: epidemiology, JAK1 biology, clinical competition, recent deals, unmet need and market attractiveness. Evidence synthesized with…
Latest Hotspot
8 min read
NCT07553988 RS-113 Metastatic castration-resistant prostate cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 July 2026
NCT07553988 clinical trial report covering RS-113, Phase 2, endpoints, sponsor, geography, readout timing and development white space.